O-113 Cisplatin plus gemcitabine with or without vinorelbine asneo-adjuvant therapy for radically treatable stage III Non small cell lung cancer (NSCLC). Preliminary results of a randomised study of the GON (Grupo Oncológico del Norte de España)

✍ Scribed by Esteban, E.; Fernández, Y.; Vieitez, J.; Villanueva, N.; De Sande, J.; Fra, J.; Muñiz, I.; Palacio, I.; Fernández, J.; Lacave, A.

• Book ID: 118572661
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 142 KB
• Volume: 49
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(05)80247-8